Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DIGITALIFT Inc. Digital marketing firm providing programmatic ad operations and strategic consulting services.	Japan	9244
D.L.S.I. HR and recruitment services for temp, fixed-term, and permanent roles across industries.	France	ALDLS
Dogwood Therapeutics, Inc. Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.	United States of America	DWTX
Doric Nimrod Air Three Limited Investment firm leasing four Airbus A380s to Emirates for shareholder returns.	Guernsey	DNA3
DP Aircraft I Limited Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.	Guernsey	DPA
DreamCIS INC. A CRO providing clinical research services for pharma, biotech, and medical device industries.	South Korea	223250
DT&CRO CO., Ltd. A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.	South Korea	383930
DUSKIN CO.,LTD. Franchises cleaning rentals and services for homes and businesses, and operates food chains.	Japan	4665
D.Western Therapeutics Institute, Inc. Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.	Japan	4576
ECHOMARKETING Co.,Ltd. Global agency accelerating sales with data-driven, full-funnel digital marketing.	South Korea	230360